CA
NZ
UK
AU
IND
US
…
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. The company operates in two segments: Technology and Professional Services. It offers ignite data and analytics platform that provides clients a single comprehensive environment to integrate and organize data from their disparate software systems; and applications, a software analytics applications build for ignite platform to analyze clients face across clinical improvement, revenue and cost improvement, ambulatory operations, measures and registries, and data and analytics. The company also provides expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. It serves academic medical centers, integrated delivery networks, community hospitals, large physician practices, accountable care organizations, health information exchanges, health insurers, life science organizations, healthcare technology vendors, and other risk-bearing entities. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Health Catalyst provides data and analytics software, applications and professional services to health systems to improve clinical, financial and operational outcomes. Long-term growth may be supported by rising demand for value-based care analytics, expansion of recurring SaaS and analytics offerings, and cross-selling into a large addressable market of hospitals and health systems, which could support margin improvement and steadier revenue.
Primary investment risks include intense competition and execution risk as the company scales recurring-revenue offerings amid long sales cycles, constrained provider budgets and sensitivity to regulatory or reimbursement changes.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | -177.26M | -69.17M | -117.79M | -141.68M | -160.11M |
| Net income | -177.97M | -69.50M | -118.15M | -137.40M | -153.21M |
| Selling general administrative | 49.56M | 56.82M | 76.56M | 61.70M | 85.93M |
| Selling and marketing expenses | 52.48M | 54.39M | 67.32M | 87.51M | 75.03M |
| Gross profit | 104.13M | 140.78M | 131.83M | 133.19M | 117.57M |
| Reconciled depreciation | 50.50M | 41.43M | 42.22M | 48.30M | 37.53M |
| Ebit | -160.85M | -52.08M | -110.50M | -140.00M | -143.65M |
| Ebitda | -110.35M | -10.65M | -68.28M | -91.71M | -106.12M |
| Depreciation and amortization | 50.50M | 41.43M | 42.22M | 48.30M | 37.53M |
| Operating income | -36.10M | -69.81M | -126.90M | -140.00M | -143.65M |
| Other operating expenses | 347.24M | 376.39M | 422.83M | 416.24M | 385.58M |
| Interest expense | 16.40M | 17.09M | 7.29M | 1.68M | 16.46M |
| Tax provision | 0.72M | 0.33M | 0.36M | -4.28M | -6.90M |
| Interest income | 7.54M | 17.98M | 16.39M | 5.69M | 0.83M |
| Net interest income | -16.72M | 0.90M | 9.10M | -1.55M | -16.48M |
| Income tax expense | 0.72M | 0.33M | 0.36M | -4.28M | -6.90M |
| Total revenue | 311.14M | 306.58M | 295.94M | 276.24M | 241.93M |
| Total operating expenses | 140.24M | 210.59M | 258.73M | 273.19M | 261.22M |
| Cost of revenue | 207.00M | 165.81M | 164.10M | 143.05M | 124.35M |
| Total other income expense net | -141.15M | 0.64M | 9.11M | -1.68M | -16.46M |
| Net income from continuing ops | -177.97M | -69.50M | -118.15M | -137.40M | -153.21M |
| Net income applicable to common shares | - | - | - | -137.40M | -153.21M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 502.64M | 858.93M | 701.81M | 752.29M | 832.10M |
| Intangible assets | 77.68M | 86.05M | 73.38M | 92.19M | 104.79M |
| Other current assets | 14.45M | 16.47M | 12.28M | 16.34M | 14.61M |
| Total liab | 256.86M | 493.72M | 334.89M | 327.28M | 310.00M |
| Total stockholder equity | 245.78M | 365.21M | 366.92M | 425.01M | 522.10M |
| Deferred long term liab | - | - | - | 2.60M | 3.00M |
| Other current liab | 18.70M | 26.34M | 23.28M | 19.69M | 28.30M |
| Common stock | 1608.84M | 1552.71M | 1484.06M | 1424.68M | 0.05M |
| Capital stock | 1608.84M | 1552.71M | 1484.06M | 1424.68M | 0.05M |
| Retained earnings | -1364.65M | -1186.67M | -1117.17M | -999.02M | -878.86M |
| Other liab | - | - | - | 0.23M | 15.76M |
| Good will | 209.07M | 259.76M | 190.65M | 185.98M | 169.97M |
| Other assets | - | - | 0.00M | 3.73M | 4.50M |
| Cash | 50.81M | 249.65M | 106.28M | 116.31M | 193.23M |
| Total current liabilities | 89.57M | 325.85M | 89.03M | 82.51M | 93.05M |
| Current deferred revenue | 56.11M | 53.28M | 55.75M | 54.96M | 56.63M |
| Net debt | 120.42M | 152.62M | 142.79M | 131.66M | 11.38M |
| Short term debt | 5.41M | 234.80M | 3.36M | 3.43M | 3.42M |
| Short long term debt | 1.63M | 231.18M | - | - | - |
| Short long term debt total | 171.24M | 402.26M | 249.07M | 247.97M | 204.61M |
| Other stockholder equity | - | - | - | -0.65M | 1400.97M |
| Property plant equipment | - | - | - | 42.59M | 44.45M |
| Total current assets | 169.31M | 465.65M | 391.20M | 427.80M | 508.39M |
| Net tangible assets | - | - | - | 146.84M | 247.34M |
| Short term investments | 44.92M | 142.35M | 211.45M | 247.18M | 251.75M |
| Net receivables | 59.13M | 57.18M | 61.19M | 47.97M | 48.80M |
| Long term debt | 151.62M | 151.18M | 228.03M | 226.52M | 180.94M |
| Inventory | - | - | 0.00M | - | - |
| Accounts payable | 9.36M | 11.43M | 6.64M | 4.42M | 4.69M |
| Accumulated other comprehensive income | 1.59M | -0.83M | 0.03M | -0.65M | -0.07M |
| Common stock total equity | - | - | - | - | 0.05M |
| Retained earnings total equity | - | - | - | - | -878.86M |
| Non currrent assets other | 6.11M | 6.02M | 6.94M | 3.73M | 4.50M |
| Non current assets total | 333.34M | 393.28M | 310.62M | 324.49M | 323.70M |
| Capital lease obligations | 17.99M | 19.91M | 21.03M | 21.45M | 23.67M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | 98.82M | -22.90M | -3.37M | -39.02M | -74.47M |
| Change to liabilities | - | - | - | -10.70M | 12.84M |
| Total cashflows from investing activities | 36.19M | -22.90M | 20.29M | -39.02M | -139.68M |
| Net borrowings | -232.29M | 151.32M | 0.00M | - | - |
| Total cash from financing activities | -235.78M | 151.75M | 2.73M | -2.61M | 264.08M |
| Change to operating activities | - | - | - | -4.00M | -8.32M |
| Net income | -177.97M | -69.50M | -118.15M | -137.40M | -153.21M |
| Change in cash | -198.83M | 143.37M | -10.04M | -76.92M | 101.27M |
| Begin period cash flow | 249.65M | 106.28M | 116.31M | 193.23M | 91.95M |
| End period cash flow | 50.81M | 249.65M | 106.28M | 116.31M | 193.23M |
| Total cash from operating activities | 0.73M | 14.56M | -33.08M | -35.27M | -23.12M |
| Issuance of capital stock | - | - | 0.00M | 0.00M | 245.18M |
| Depreciation | 50.50M | 41.43M | 42.22M | 48.30M | 37.53M |
| Other cashflows from investing activities | -20.54M | -14.77M | -13.04M | - | -54.76M |
| Change to inventory | - | - | - | - | -8.32M |
| Change to account receivables | -1.81M | 4.28M | -13.66M | 0.79M | 0.10M |
| Sale purchase of stock | -5.00M | 0.00M | -1.81M | -8.39M | 270.37M |
| Other cashflows from financing activities | -235.78M | -2.15M | 4.54M | 1.81M | 18.90M |
| Change to netincome | - | - | - | 66.24M | 76.00M |
| Capital expenditures | 0.97M | 16.40M | 14.31M | 17.41M | 18.47M |
| Change receivables | - | - | - | - | 0.10M |
| Cash flows other operating | - | - | - | - | -4.44M |
| Cash and cash equivalents changes | - | - | - | - | 101.28M |
| Change in working capital | -15.11M | -0.66M | -13.67M | -13.91M | 4.62M |
| Stock based compensation | 27.01M | 40.13M | 55.76M | 72.10M | 65.14M |
| Other non cash items | 116.22M | 3.08M | 0.75M | 0.16M | 29.93M |
| Free cash flow | -0.24M | -1.84M | -47.39M | -52.68M | -41.59M |
Sector: Healthcare Industry: Health Information Services
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| HCAT Health Catalyst Inc |
-0.07 4.55% |
1.36 | - | 10.00 | 0.44 | 1.37 | 0.70 | -4.96 |
| VEEV Veeva Systems Inc Class A |
-4.88 1.60% |
299.89 | 43.49 | 29.59 | 12.48 | 5.79 | 10.39 | 33.41 |
| PMCUF Pro Medicus Limited |
0.68 0.48% |
142.50 | 64.90 | 90.91 | 49.11 | 38.05 | 65.12 | 83.47 |
| TEM Tempus AI, Inc. Class A Common Stock |
-4.81 6.06% |
74.62 | - | - | 8.68 | 25.39 | 8.33 | - |
| MTHRY M3 Inc |
-0.07 1.22% |
5.66 | 31.84 | 26.25 | 0.05 | 4.60 | 0.04 | 0.12 |
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. The company operates in two segments: Technology and Professional Services. It offers ignite data and analytics platform that provides clients a single comprehensive environment to integrate and organize data from their disparate software systems; and applications, a software analytics applications build for ignite platform to analyze clients face across clinical improvement, revenue and cost improvement, ambulatory operations, measures and registries, and data and analytics. The company also provides expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. It serves academic medical centers, integrated delivery networks, community hospitals, large physician practices, accountable care organizations, health information exchanges, health insurers, life science organizations, healthcare technology vendors, and other risk-bearing entities. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.
10897 South River Front Parkway, South Jordan, UT, United States, 84095
801 708 6800
1200
| Name | Title | Year Born |
|---|---|---|
| Mr. Daniel D. Burton | CEO & Director | 1975 |
| Mr. Bryan Truman Hunt | Chief Financial Officer | 1987 |
| Mr. Paul Horstmeier | Chief Operating Officer | 1961 |
| Mr. Daniel H. Orenstein | Gen. Counsel & Sec. | 1970 |
| Mr. J. Patrick Nelli Jr. | Sr. Advisor | NA |
| Mr. Jason Alger | Chief Accounting Officer | 1984 |
| Mr. Dave Ross | Chief Technology Officer | NA |
| Mr. Jason Jones | Chief Analytics & Data Science Officer and GM of Data & Analytics Platform | NA |
| Mr. Adam Brown | Sr. VP of Investor Relations and Financial Planning & Analysis | NA |
| Mr. Kyle J. Salyers | Sr. VP of Corp. Devel. | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Download a free report with stock ideas and industry insights for general information.
Download Free Report Now →
Basic Materials
-1.40%
Communication Services
-0.45%
Consumer Cyclical
-0.55%
Consumer Defensive
-0.01%
Energy
-0.01%
Financial Services
-0.40%
Financials
-0.15%
Healthcare
-1.15%
Industrials
-0.46%
Real Estate
-0.29%
Technology
-1.22%
Utilities
-0.10%
Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.
Portfolio
Watchlist
+0.55%
Please wait processing your request...